Free Trial
NYSE:LH

Laboratory Co. of America (LH) Stock Price, News & Analysis

$210.90
+1.18 (+0.56%)
(As of 07/26/2024 ET)
Today's Range
$209.95
$213.58
50-Day Range
$192.50
$216.50
52-Week Range
$191.97
$234.09
Volume
393,546 shs
Average Volume
713,789 shs
Market Capitalization
$17.78 billion
P/E Ratio
42.43
Dividend Yield
1.37%
Price Target
$241.29

Laboratory Co. of America MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.79 Rating Score
Upside/​Downside
14.4% Upside
$241.29 Price Target
Short Interest
Healthy
2.44% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.79mentions of Laboratory Co. of America in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$1.02 M Sold Last Quarter
Proj. Earnings Growth
6.87%
From $14.84 to $15.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.68 out of 5 stars

Medical Sector

69th out of 936 stocks

Medical Laboratories Industry

2nd out of 18 stocks

LH stock logo

About Laboratory Co. of America Stock (NYSE:LH)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

LH Stock Price History

LH Stock News Headlines

African american woman meeting with medic on videocall, attending telemedicine videoconference with webcam to discuss about healthcare and treatment. Online telehealth conference.
Is This Telehealth Stock a Buy After the Recent Pullback? (LH)
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Labcorp Declares Quarterly Dividend
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Laboratory Corporation of America Holdings
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Lancorp Launches First Trimester Preeclampsia Screening Test
See More Headlines
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/25/2024
Ex-Dividend for 6/12 Dividend
5/24/2024
Dividend Payable
6/12/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/01/2024
Ex-Dividend for 9/13 Dividend
8/29/2024
Dividend Payable
9/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
Health Care Services
CUSIP
50540R40
Employees
67,000
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$241.29
High Stock Price Target
$270.00
Low Stock Price Target
$210.00
Potential Upside/Downside
+14.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Net Income
$418 million
Pretax Margin
4.83%

Debt

Sales & Book Value

Annual Sales
$12.16 billion
Cash Flow
$20.48 per share
Book Value
$92.76 per share

Miscellaneous

Free Float
83,583,000
Market Cap
$17.78 billion
Optionable
Optionable
Beta
1.05

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Should I Buy Laboratory Co. of America Stock? LH Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

  • Strong Quarterly Earnings: Laboratory Co. of America Holdings reported earnings per share of $3.68 for the last quarter, surpassing analyst estimates by $0.20. This indicates a solid financial performance.
  • Consistent Revenue Growth: The company's quarterly revenue of $3.18 billion was higher than analyst expectations, showing a 4.6% increase compared to the same period last year.
  • Insider Buying: Despite recent insider selling, insider ownership of 0.85% can still be seen as a positive sign, indicating confidence in the company's future prospects.
  • Market Performance: The stock has a moderate buy rating with a consensus target price of $241.86, suggesting potential for price appreciation.
  • Stable Financial Ratios: With a debt-to-equity ratio of 0.39 and healthy current and quick ratios, the company exhibits strong financial stability.

Cons

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

  • Recent Insider Selling: Insiders have sold a significant number of shares in the last quarter, totaling 18,469 shares worth $3,959,058. This could raise concerns about insider sentiment.
  • Stock Price Volatility: The stock has experienced fluctuations, trading down $2.13 on the latest trading day. Investors may face short-term price volatility.
  • High Price-to-Earnings Ratio: With a PE ratio of 41.30, the stock may be considered relatively expensive compared to industry peers, potentially limiting immediate upside potential.
  • Decrease in Trading Volume: The average trading volume has decreased, which could indicate weakening investor interest or liquidity concerns.
  • Market Sentiment: While the stock has a moderate buy rating, investors should consider market conditions and potential risks that could impact the company's performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 1, 2024. Please send any questions or comments about these Laboratory Co. of America pros and cons to contact@marketbeat.com.

LH Stock Analysis - Frequently Asked Questions

How have LH shares performed this year?

Laboratory Co. of America's stock was trading at $227.29 on January 1st, 2024. Since then, LH shares have decreased by 7.2% and is now trading at $210.90.
View the best growth stocks for 2024 here
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) issued its earnings results on Thursday, April, 25th. The medical research company reported $3.68 EPS for the quarter, topping analysts' consensus estimates of $3.48 by $0.20. Laboratory Co. of America's quarterly revenue was up 4.6% compared to the same quarter last year.
Read the conference call transcript
.

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America Chief Executive Officer Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among the company's employees.

Does Laboratory Co. of America have any subsidiaries?

Laboratory Co. of America subsidiaries include Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and more.

Who are Laboratory Co. of America's major shareholders?

Top institutional investors of Laboratory Co. of America include Bank of New York Mellon Corp (1.91%), Allspring Global Investments Holdings LLC (1.90%), AMI Asset Management Corp (0.25%) and M&G Plc (0.23%). Insiders that own company stock include Glenn A Eisenberg, Kerrii B Anderson, Brian J Caveney, Paul R Kirchgraber, Der Vaart Sandra D Van, Mark S Schroeder, Amy B Summy, Jonathan P Divincenzo, Peter J Wilkinson, Peter M Neupert, R Sanders Williams and Dwight Gary Gilliland.
View institutional ownership trends
.

How do I buy shares of Laboratory Co. of America?

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA) and Abbott Laboratories (abt).

This page (NYSE:LH) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners